Skip to Content
 

News: Home Page Latest News

Top cancer researchers reveal latest findings at VICC science retreat

Friday, May 12th, 2017

Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer. “Cancer Epigenetics — From Mechanisms to Therapies” was the topic of the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat held […]

Vanderbilt’s Christine Lovly Elected to American Society for Clinical Investigation

Thursday, April 27th, 2017

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected to The American Society for Clinical Investigation (ASCI). The ASCI is an elite honor society of physician-scientists. The Society, founded in 1908, is home to nearly 3,000 members from the upper ranks of academic medicine […]

Vanderbilt’s Pietenpol joins Sledge as a Chief Scientific Advisor for Susan G. Komen

Thursday, April 6th, 2017

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen. Jennifer Pietenpol, Ph.D. She joins George Sledge Jr., M.D., professor of Medicine at Stanford University Medical Center, […]

Annual Meharry-Vanderbilt-TSU Cancer Partnership retreat April 8

Friday, March 24th, 2017

The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on Saturday, April 8, from 8:30 a.m. to 2:30 p.m. The retreat will be held on the Meharry Medical College campus in the Harold D. West Basic Sciences Building, Room M001. This year’s […]

Study takes 3-D perspective on colorectal cancer

Friday, March 24th, 2017

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus. Determined to reduce the death toll, researchers at Vanderbilt University Medical Center recently put on their 3-D “glasses” and took […]

New technique helps ease ear tumor surgery

Thursday, February 16th, 2017

Last fall, the Vanderbilt Bill Wilkerson Center became the second facility in the country and third in the world to use a fully endoscopic surgical technique to remove an acoustic neuroma, a rare benign tumor on the balance and hearing nerves. Alejandro Rivas, M.D., associate professor of Otolaryngology and Neurological Surgery, performed the surgery along […]

Softening tumor tissue could aid cancer treatments

Thursday, January 19th, 2017

Normally, the glue that holds cells together in the human body – what scientists call the extracellular matrix – is soft and pliable. But when a metastatic tumor forms it causes the matrix surrounding it to stiffen. According to a new study, this mechanical effect produces changes in the blood vessels that feed the tumor […]

Morton to help lead blood disorders treatment efforts

Thursday, January 12th, 2017

Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. Colleen Morton, M.D. In the newly created position, Morton oversees VUMC’s treatment of patients with bleeding disorders like von Willebrand disease, blood […]

Award honors Beauchamp’s teaching, research

Thursday, November 17th, 2016

R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences and the John Clinton Foshee Distinguished Professor of Surgery, has been selected to receive the 2016 Dr. Rodman E. and Thomas G. Sheen Award from the New Jersey American College of Surgeons (ACS) Chapter. The award was established in 1938 by Thomas Sheen in […]

Study details rare heart risk of certain cancer therapies

Monday, November 7th, 2016

Combination therapy using two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response. In a study led by Vanderbilt University Medical Center (VUMC) investigators and published in the Nov. 3 issue of the New England Journal of Medicine, researchers describe two cases of […]

Next Page »« Previous Page